Active surveillance (AS) has been introduced as an observational strategy to delay or avoid
curative treatment without compromising long‐term cancer‐specific survival. The 10 studies …

… Values of CMRO 2 , declined significantly only in F-M1, but tended toward significant declines
in both P-S1 and temporal cortex. The magnitude of OEF increased significantly in F-M1, P-…

Charge neutral steric block oligonucleotide analogues, such as peptide nucleic acids (PNA)
or phosphorodiamidate morpholino oligomers (PMO), have promising biological and …

Background Enzalutamide is an oral androgen-receptor inhibitor that prolongs survival in
men with metastatic castration-resistant prostate cancer in whom the disease has progressed …

THE Greenland ice sheet offers the most favourable conditions in the Northern Hemisphere
for obtaining high-resolution continuous time series of climate-related parameters. Profiles of …

Genome-wide association studies (GWAS) and fine-mapping efforts to date have identified
more than 100 prostate cancer (PrCa)-susceptibility loci. We meta-analyzed genotype data …

Prostate cancer is a highly heritable disease with large disparities in incidence rates across
ancestry populations. We conducted a multiancestry meta-analysis of prostate cancer …

Genome-wide association studies (GWAS) have identified 76 variants associated with
prostate cancer risk predominantly in populations of European ancestry. To identify additional …

… hippuric acid clearance as a measure of the effective renal blood-flow, and TmpAn
expressing the tubular excretory mass for p-amino hippuric acid; also, Addis’s concentration …

Enzalutamide significantly improved radiographic progression-free survival (rPFS) and
overall survival (OS) among men with chemotherapy-naïve metastatic castration-resistant …